Product Program year 2025 Source: CMS Open Payments

Orsiro Mission

Device Cardiology/Vascular Diseases

PDI 07640130456341

Open in the dashboard

General payments

$480,267

1,835 payments

Research payments

$1,004,401

3,867 payments

Through program year 2025, $480,267 in general payments and $1,004,401 in research payments were reported against Orsiro Mission (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $25,002 300
2025 Research $430,787 1,205
2024 General $238,882 668
2024 Research $257,111 1,177
2023 General $216,383 867
2023 Research $316,502 1,485

Breakdown

Who paid General payments · program years 2023–2025
  1. Biotronik Inc. $480,267 1,835 payments
Top recipients General payments · program year 2025
  1. Ajay Kirtane Interventional Cardiology · New York, NY $5,542 22% · 4 payments
  2. Rajesh Swaminathan Interventional Cardiology · Durham, NC $600 2% · 1 payment
  3. Reza Nazari Cardiovascular Disease · Turlock, CA $540 2% · 7 payments
  4. Raul Mercado Garcia Cardiovascular Disease · Temple, TX $529 2% · 6 payments
  5. Vamsi Krishna Interventional Cardiology · Kyle, TX $440 2% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $16,770 68% · 93 practitioners
  2. Cardiovascular Disease Internal Medicine $5,571 23% · 55 practitioners
  3. Internal Medicine $578 2% · 7 practitioners
  4. Vascular Surgery Surgery $323 1% · 6 practitioners
  5. Physician Assistant $226 <1% · 4 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $7,873 31% · 21 recipients
  2. Texas $5,186 21% · 33 recipients
  3. California $3,547 14% · 31 recipients
  4. North Carolina $1,174 5% · 8 recipients
  5. Florida $774 3% · 5 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,835 general · 3,867 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record